A biotechnology firm has developed a new monoclonal antibody designed to target and destroy malignant tumour cells. Before this treatment can be approved for clinical trials on human patients, researchers must conduct pre-clinical testing.
State two purposes of carrying out these pre-clinical tests on cell cultures and laboratory animals.
